NCT06753175

Brief Summary

Sixty female patients with lymphedema post mastectomy, aged 30-55 years, will be selected from Minia Oncology Institute. The participants will be randomly distributed into two equal groups:

  1. 1.Group A (CDT + Underwater Galvanic Stimulation group):
  2. 2.Group B (CDT group):

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 31, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

January 15, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

2 months

First QC Date

December 22, 2024

Last Update Submit

September 13, 2025

Conditions

Keywords

Mastectomy

Outcome Measures

Primary Outcomes (3)

  • Measuring pain intensity:

    The Visual Analogue Scale (VAS) will be employed. This 10cm line, marked from "no pain"(zero) to "worst pain (10) imaginable," will be used to represent the pain continuum. Patients will be guided on how to interact with the VAS scale, ensuring clarity and ease of use.

    2 months

  • Measuring the volume of a patient's upper limb:

    Essential tools such as a flexible tape measure, marker pen or pencil, and a recording sheet will be collected. Measurements will be taken at specific anatomical landmarks every 4 cm, including the wrist, the midpoint of the forearm, and where the upper arm meets the shoulder. The tape measure will be applied snugly around the limb without tightening, ensuring consistency in tension. Both the affected and non-affected limbs will be measured for comparison, with a more than 10% volume increase indicating potential edem. Circumference measurements will be recorded to the nearest 0.1 cm without indenting the skin. The frustum of a cone formula will be used to estimate each arm segment's volume, with repeated measures for ongoing assessment.

    2 months

  • Improvement in quality of life:

    Assessed using the Lymphedema Quality of Life Questionnaire (LYMQOL).

    2 months

Study Arms (2)

Group A (CDT + Underwater Galvanic Stimulation group

EXPERIMENTAL

This group includes 30 patients who will receive underwater galvanic stimulation by 4-cell bath with CDT for 2 months (3times/week) in addition to their medical treatment.

Device: underwater galvanic stimulation by 4-cell bathOther: Complete Decongestive Therapy (CDT):

Group B (CDT group):

ACTIVE COMPARATOR

This group includes 30 patients who will receive only CDT for 2 months (3times/week) in addition to their medical treatment.

Interventions

Underwater Galvanic Stimulation: * Equipment: 4-cell bath * Procedure: Patients will immerse their affected limbs in the 4-cell bath. Electrical stimulation will be applied at a frequency of 15 Hz and intensity of 20 mA for 20 minutes, 3 times per week (Han et al. 2020).

Group A (CDT + Underwater Galvanic Stimulation group

Complete Decongestive Therapy (CDT): * Manual Lymphatic Drainage (MLD): 60 minutes per session, 3 days per week. * Compression Therapy: Multilayer bandaging applied after MLD. * Exercise: Specific exercises performed with compression in place. * Skin Care: Routine skin and nail care to prevent infections (Curlett et al. 2020).

Group A (CDT + Underwater Galvanic Stimulation group

Eligibility Criteria

Age30 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ▪ Female patients with lymphedema post mastectomy
  • Aged 30-55 years
  • No history of cardiac or renal disease
  • No contraindications to electrotherapy
  • All patients enrolled to the study will have their informed consent.

You may not qualify if:

  • ▪ Cardiac diseases.
  • Patients with active cancer
  • Patients with pacemakers or other implantable devices
  • Patients with a history of seizures or epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Giza, Egypt

Location

MeSH Terms

Conditions

Lymphedema

Interventions

Bathscarbohydrate-deficient transferrin

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

BalneologyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Physical therapy for surgery

Study Record Dates

First Submitted

December 22, 2024

First Posted

December 31, 2024

Study Start

January 15, 2025

Primary Completion

March 15, 2025

Study Completion

May 15, 2025

Last Updated

September 18, 2025

Record last verified: 2025-09

Locations